M MELT PHARMACEUTICALS
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97539612
- Registration number
- 7508701
- Mark type
- Design + words
- Filed
- 08 Aug 2022
- Published for opposition
- 29 Aug 2023
- Registered
- 17 Sept 2024
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 042 — Scientific and technological services: Research and development of medications; Research and development of medications for preoperative use; Research and development of pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
Owner
- HARROW IP, LLC, NASHVILLE, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
- Melt Pharmaceuticals, Inc., Nashville, TN, US
Prosecution history
- 18 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Apr 2024 — USE AMENDMENT FILED
- 15 May 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2023 — PUBLISHED FOR OPPOSITION
- 09 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jul 2023 — EXAMINER'S AMENDMENT ENTERED